Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice

References

• Akirav E, Bergman C, Hill M, Ruddle N. 2009. Depletion of CD4+CD25+ T-cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens. J Neurosci Res. 87:3511–3519.
   PubMed Web of Science ®Google Scholar
• Al-Shammri S, Rawoot P, Azizieh F, Abuqoora A, Hanna M, Saminathan TR, Raghupathy R. 2004. TH1/TH2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 222:21–27.
   PubMed Web of Science ®Google Scholar
• Anderton S. 2010. Treg and T-effector cells in autoimmune CNS inflammation: A delicate balance, easily disturbed. Eur J Immunol. 40:3321–3324.
   PubMed Web of Science ®Google Scholar
• Bebo B, Dehghani B, Foster S, Kurniawan A, Lopez F, Sherman L. 2009. Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis. Glia. 57:777–790.
   PubMed Web of Science ®Google Scholar
• Berard J, Zarruk J, Arbor N, Prat A, Yong V, Jacques F, Akira S, David S. 2012. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia. 60:1145–1159.
   PubMed Web of Science ®Google Scholar
• Bodhankar S, Galipeau D, Vandenbark AA, Offner H. 2013. PD-1 interaction with PD-L1 but not PD-L2 on B-cells mediates protective effects of estrogen against EAE. J Clin Cell Immunol. 4:143.
   PubMedGoogle Scholar
• Bodhankar S, Wang C, Vandenbark A, Offner H. 2011. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B-cells. Eur J Immunol. 41:1165–1175.
   PubMed Web of Science ®Google Scholar
• Cala CM, Moseley CE, Steele C, Dowdy SM, Cutter GR, Ness JM, DeSilva TM. 2016. T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis. J Neuroimmunol. 297:1–8.
   PubMed Web of Science ®Google Scholar
• Chen X, Shen Y, Liang Q, Flavell R, Hong Z, Yin Z, Wang M. 2014. Effect of bavachinin and its derivatives on T-cell differentiation. Int Immunopharmacol. 19:399–404.
   PubMed Web of Science ®Google Scholar
• Dai H, Ciric B, Zhang G, Rostami A. 2012. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. J Neuroimmunol. 245:1–7.
   PubMed Web of Science ®Google Scholar
• El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F, Zhang G, Dittel B, Rostami A. 2011. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol. 12:568–575.
   PubMed Web of Science ®Google Scholar
• Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, Delignat S, Elluru S, Bayry J, Lacroix-Desmazes S, et al. 2008. Expansion of CD4+CD25+ regulatory T-cells by intravenous immunoglobulin: A critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 111:715–722.
   PubMed Web of Science ®Google Scholar
• Fernando V, Omura S, Sato F, Kawai E, Martinez N, Elliott S, Yoh K, Takahashi S, Tsunoda I. 2014. Regulation of an autoimmune model for multiple sclerosis in TH2-biased GATA3 transgenic mice. Intl J Mol Sci. 15:1700–1718.
   PubMed Web of Science ®Google Scholar
• Fletcher J, Lalor S, Sweeney C, Tubridy N, Mills K. 2010. T-cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 162:1–11.
   PubMed Web of Science ®Google Scholar
• Fontenot J, Dooley J, Farr A, Rudensky A. 2005. Developmental regulation of Foxp3 expression during ontogeny. J Exp Med. 202:901–906.
   PubMed Web of Science ®Google Scholar
• Haghmorad D, Amini A, Mahmoudi M, Rastin M, Hosseini M, Mahmoudi M. 2014a. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariwctomized and pregnant C57BL/6 mice through expansion of Treg and TH2 cells. J Neuroimmunol. 277:85–95.
   PubMed Web of Science ®Google Scholar
• Haghmorad D, Mahmoudi M, Mahmoudi M, Rab S, Rastin M, Shegarfi H, Azizi G, Mirshafiey A. 2014b. Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Med J. 29:185–189.
   PubMedGoogle Scholar
• Harrirchian MH, Honarvar NM, Koohdani F, Bitarafan S, Siassi F, Jafarirad S, Abdolahi M, Salehi E, Saharian MA, Rouystaee H, et al. 2014. The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial. Acta Med Iranica. 52:94.
   PubMedGoogle Scholar
• Hedegaard CJ, Krakauer M, Bendtzen K, Lund H, Sellebjerg F, Nielsen CH. 2008. T-helper cell type 1 (TH1), TH2 and TH17 responses to myelin basic protein and disease activity in multiple sclerosis. Immunology. 125:161–169.
   PubMed Web of Science ®Google Scholar
• Horstmann L, Schmid H, Heinen AP, Kurschus F, Dick H, Joachim S. 2013. Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J Neuroinflammation. 10:120.
   PubMed Web of Science ®Google Scholar
• Huehnchen P, Prozorovski T, Klaissle P, Lesemann A, Ingwersen J, Wolf S, Kupsch A, Aktas O, Steiner B. 2011. Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation. Glia. 59:132–142.
   PubMed Web of Science ®Google Scholar
• Koutrolos M, Berer K, Kawakami N, Wekerle H, Krishnamoorthy G. 2014. Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun. 2:163.
   PubMedGoogle Scholar
• Kroenke M, Carlson T, Andjelkovic A, Segal B. 2008. IL-12- and IL-23-modulated T-cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 205:1535–1541.
   PubMed Web of Science ®Google Scholar
• Lavi Arab F, Rastin M, Faraji F, Zamani Taghizadeh Rabe S, Tabasi N, Khazaee M, Haghmorad D, Mahmoudi M. 2015. Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus. Immunopharmacol Immunotoxicol. 37:12–18.
   PubMed Web of Science ®Google Scholar
• Leuenberger T. 2012. Regulatory CD4⁺ and CD8⁺ T-cells as candidates for regenerative therapies in a mouse model of multiple sclerosis. Berlin: Freie Universität.
   Google Scholar
• Liston A, Gray D. 2014. Homeostatic control of regulatory T-cell diversity. Nat Rev Immunol. 14:154–165.
   PubMed Web of Science ®Google Scholar
• Liu R, Wen Y, Perez E, Wang X, Day A, Simpkins J, Yang S. 2005. 17β-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res. 1060:55–61.
   PubMed Web of Science ®Google Scholar
• Lovett-Racke AE, Yang Y, Racke MK. 2011. TH1 versus TH17: Are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta. 1812:246–251.
   PubMed Web of Science ®Google Scholar
• Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa K. 2012. Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis. Glia. 60:1053–1066.
   PubMed Web of Science ®Google Scholar
• Markovic-Plese S, McFarland H. 2001. Immunopathogenesis of the multiple sclerosis lesion. Curr Neurol Neurosci Rep. 1:257–262.
   PubMedGoogle Scholar
• Miller A, Shapiro S, Gershtein R, Kinarty A, Rawashdeh H, Honigman S, Lahat N. 1998. Treatment of multiple sclerosis with co-polymer-1 (Copaxone): implicating mechanisms of TH1 to TH2/TH3 immune-deviation. J Neuroimmunol. 92:113–121.
   PubMed Web of Science ®Google Scholar
• Miller S, Karpus W. 2007. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol. Chapter Unit-15.1.
   PubMedGoogle Scholar
• Milo R, Kahana E. 2010. Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmun Rev. 9:A387–A394.
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Haghmorad D, Namaki S, Ghazavi A, Ekhtiari P, Mirshafiey A. 2010. Therapeutic effect of EDTA in experimental model of multiple sclerosis. Immunopharmacol Immunotoxicol. 32:321–326.
   PubMed Web of Science ®Google Scholar
• Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Mahmoudi M. 2016. Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing TH1 and TH17 cells and up-regulating regulatory T-cells. Nanomedicine. 12:1961–1971.
   PubMed Web of Science ®Google Scholar
• Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Tabasi N, Zamani S, Aghaee A, Salehipour Z, Mahmoudi M. 2015. St. John’s Wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells. J Immunotoxicol. 13:364–374.
   PubMed Web of Science ®Google Scholar
• Oreja-Guevara C, Ramos-Cejudo J, Aroeira LS, Chamorro B, Diez-Tejedor E. 2012. TH1/TH2 cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab. BMC Neurol. 12:95.
   PubMed Web of Science ®Google Scholar
• Papenfuss T, Rogers C, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre C. 2004. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol. 150:59–69.
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y, Wang Y, Hood L, Zhu Z, Tian Q, et al. 2005. A distinct lineage of CD4 T-cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 6:1133–1141.
   PubMed Web of Science ®Google Scholar
• Pelfrey C, Rudick R, Cotleur A, Lee J, Tary-Lehmann M, Lehmann P. 2000. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J Immunol. 165:1641–1651.
   PubMed Web of Science ®Google Scholar
• Polanczyk M, Hopke C, Vandenbark A, Offner H. 2007. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol. 19:337–343.
   PubMed Web of Science ®Google Scholar
• Polanczyk M, Jones R, Subramanian S, Afentoulis M, Rich C, Zakroczymski M, Cooke P, Vandenbark AA, Offner H. 2004. T-lymphocytes do not directly mediate protective effect of estrogen on experimental autoimmune encephalomyelitis. Am J Pathol. 165:2069–2077.
   PubMed Web of Science ®Google Scholar
• Rastin M, Mahmoudi M, Hatef M, Sahebari M, Tabasi N, Haghmorad D, Nosratabadi R, Zamani S, Khazaee M, Masoudian M. 2013. T-lymphocyte apoptosis in systemic lupus erythematosus patients. Iran J Basic Med Sci. 16:936–941.
   PubMed Web of Science ®Google Scholar
• Rostami A, Ciric B. 2013. Role of TH17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci. 333:76–87.
   PubMed Web of Science ®Google Scholar
• Shin J, Yang S, Jeong S, Park H, Choi Y, Park E. 2013. Activation of ER-β reduces blood-brain barrier breakdown following ischemic injury. Neuroscience. 235:165–173.
   PubMed Web of Science ®Google Scholar
• Sinha S, Kaler L, Proctor T, Teuscher C, Vandenbark A, Offner H. 2008. IL-13-mediated gender difference in susceptibility to autoimmune encephalomyelitis. J Immunol. 180:2679–2685.
   PubMed Web of Science ®Google Scholar
• Spence R, Hamby M, Umeda E, Itoh N, Du S, Wisdom A, Cao Y, Bondar G, Lam J, Ao Y, et al. 2011. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA. 108:8867–8872.
   PubMed Web of Science ®Google Scholar
• Spence R, Voskuhl R. 2012. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol. 33:105–115.
   PubMed Web of Science ®Google Scholar
• Stephens L, Malpass K, Anderton S. 2009. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg cells. Eur J Immunol. 39:1108–1117.
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Proctor T, Vandenbark A, Offner H. 2010. Down-modulation of programmed death 1 alters regulatory T-cells and promotes experimental autoimmune encephalomyelitis. J Neurosci Res. 88:7–15.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hong J, Sun W, Xu G, Li N, Chen X, Liu A, Xu L, Sun B, Zhang JZ. 2006. Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25− T-cells to CD4+ Tregs. J Clin Invest. 116:2434–2441.
   PubMed Web of Science ®Google Scholar
• Whitacre C, Reingold S, O’Looney P. 1999. A gender gap in autoimmunity. Science. 283:1277–1278.
   PubMed Web of Science ®Google Scholar
• Yates M, Li Y, Chlebeck P, Offner H. 2010. GPR30, but not estrogen receptor-α, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol. 11:20.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lund H, Mia S, Parsa R, Harris R. 2014. Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia. 62:804–817.
   PubMed Web of Science ®Google Scholar
• Zhou X, Bailey-Bucktrout S, Jeker L, Bluestone J. 2009. Plasticity of CD4+ FoxP3+ T-cells. Curr Opin Immunol. 21:281–285.
   PubMed Web of Science ®Google Scholar
• Zhu B, Trikudanathan S, Zozulya A, Sandoval-Garcia C, Kennedy J, Atochina O, Norberg T, Castagner B, Seeberger P, Fabry Z, et al. 2011. Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. Clin Immunol. 142:351–361.
   PubMed Web of Science ®Google Scholar
• Zozulya AL, Wiendl H. 2008. The role of regulatory T-cells in multiple sclerosis. Nat Clin Pract Neurol. 4:384–398.
   PubMedGoogle Scholar